Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adiponectin and Its Role in the Treatment of Patients With Metabolic Disorders

NCT07539584 is registered in ClinicalTrials.gov with Moscow Regional Research and Clinical Institute (MONIKI) as lead sponsor.

NCT NCT07539584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07539584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adiponectin and Its Role in the Treatment of Patients With Metabolic Disorders
Lead sponsor
Moscow Regional Research and Clinical Institute (MONIKI)
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2022
Completion date
April 8, 2024
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated fatty liver disease (mafld), type 2 diabetes mellitus (t2dm)